|Fuller et al v. Chattem, Inc.
21-cv-5436, N.D. Cal.
|Allegations||Making misleading pain relief claims
Misleadingly marketing the product as “Max Strength Lidocaine” when other products deliver more lidocaine and are more effective
Misleadingly marketing the patch as “fast acting” when it does not provide immediate pain relief
Falsely claiming that the product provides 12 hours of pain relief when it does not stay on for even six hours
Falsely marketing product as compliant with FDA regulations when it is not